戻る Agenda
Session 5: The Risk Management Plan (RMP) and Risk Evaluation and Mitigation Strategies (REMS)
Session Chair(s)
Sven Schirp
Head of Global Pharmacovigilance Writing
Boehringer Ingelheim Pharma GmbH & Co. KG, Germany
- Scope and content
- Overview of relevant data and data sources
- Develop key messages